News
Regeneron (REGN) stock was upgraded to Buy and AbbVie (ABBV) stock was downgraded at Citi based on policy risks under Trump's drug reforms. Read more here.
Zacks Investment Research on MSN3d
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Hurts SalesBayer AG BAYRY reported first-quarter 2025 core earnings of 66 cents per American Depositary Receipt (ADR), beating the Zacks ...
Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback